Introduction
The formation of specific synaptic connections is generated in part by the molecular mechanisms controlling growth cone guidance and target recognition (reviewed by Goodman and Shatz, 1993; Goodman, 1994) . Pathway and target recognition is mediated by a range of mechanisms, including contact-mediated attraction, chemoattraction, contact-mediated repulsion, and chemorepulsion. Members of a variety of gene families have been implicated to function in vivo as signals for pathfinding and targeting, including, for example, members of the immunoglobulin (Grenningloh et al., 1991; Ramos et al., 1993; Lin et al., 1994; Chiba et al., 1995) leucine-rich repeat (Noseet al., 1992 (Noseet al., ,1994 , netrin/UNC-6 (Hedgecock et al., 1990; lshii et al., 1992; Hamelin et al., 1993; Serafini et al., 1994; Kennedyet al., 1994) and semaphorin (Kolodkin et al., 1992 (Kolodkin et al., , 1993 Luo et al., 1993) gene families.
The semaphorins are a family of cell surface and secreted proteins that are conserved from insects to humans. Semaphorins are -750 amino acids in length (including signal sequence) and are defined by a conserved -500 amino acid extracellular semaphorin domain containing 14-16 cysteines, many blocks of conserved resiPresent address: Department of Neuroscience, Johns Hopkins University Medical School, Baltimore, Maryland 21205. dues, and no obvious repeats (Kolodkin et al., 1992 (Kolodkin et al., ,1993 Luo et al., 1993) . The transmembrane semaphorins have an additional -60 amino acid stretch, a transmembrane domain, and a 60-110 amino acid cytoplasmic domain. The secreted semaphorins have an additional -20 amino acid stretch, a single immunoglobulin domain, and a 70-120 amino acid C-terminal region. In addition, two semaphorins are encoded in viral genomes (Kolodkin et al., 1993) .
Two complementary sets of results suggest that semaphorins can function as signals that guide growth cones. First, semaphorin I (Kolodkin et al., 1992) a transmembrane semaphorin in insects, functions in the grasshopper limb bud to stall and then steer a pair of growth cones as they encounter epithelial cells expressing it. Semaphorin I also prevents the axons that encounter it from defasciculating and inhibits branching. Second, collapsin, a secreted semaphorin in chick, in vitro can cause the collapse of growth cones from dorsal root ganglion neurons (Luo et al., 1993) .
Semaphorin II is a secreted semaphorin in Drosophila that is dynamically expressed during embryonic development by a subset of neurons in the central nervous system (CNS) and by a single large thoracic muscle in the periphery (Kolodkin et al., 1993) . Its transient expression by a specific muscle during motoneuron outgrowth and synapse formation suggests that, among its potential roles, semaphorin II might function as a secreted target-derived signal that regulates the formation of synaptic connections.
The generation of neuromuscular specificity in Drosophila provides an ideal system for testing the in vivo function of such a putative guidance and targeting molecule because much is already known about the cellular environment, pathfinding, and targeting events that underlie its development (e.g., Sink and Whitington, 1991; Van Vactor et al., 1993; Keshishian et al., 1993; Broadie et al., 1993) . All motoneuron growth cones and axons express fasciclin II during axon outgrowth and synapse formation (Van Vactor et al., 1993) and thus can be visualized using the 1 D4 monoclonal antibody (MAb) that recognizes fasciclin II (G. Helt and C. S. G., unpublished data). Moreover, some embryonic motoneurons (e.g., RP3 and RPl) can be penetrated with microelectrodes and filled with dye to reveal their growth cones and terminals (Sink and Whitington, 1991) .
To test the in vivo function of semaphorin II during growth cone guidance and target recognition, we created transgenic Drosophila that express semaphorin II by muscles that normally do not express it. The results show that semaphorin II can function as an inhibitory signal during target recognition. Semaphorin II inhibits two identified motoneuron growth cones (RP3 and DCl) from forming normal synaptic terminal arborizationson their target muscles, while two other growth cones (RPl and RP4) appear unresponsive to contact with the protein. 
Results
Semaphorin II is normally expressed by ventral muscle 33 in thoracic segment T3 (Hooper, 1986) (Figures 16 and  2A ). On either side in each larval abdominal segment from A2 to A7 in Drosophila, there are a total of 30 muscles (l-30), including four prominent internal ventral longitudinal muscles (from ventral to dorsal): 7, 6, 13, and 12 (Figures 1A and 28) . The ventral muscles in the first abdominal segment (Al) are largely identical to those found in A2-A7, except for one additional muscle, 31 (Hooper, 1986) just internal to muscles 7, 6, and 13 (Al is also missing two muscles, 17and 25; Bate, 1993) . The pattern of ventral muscles in segment T3 displays a number of differences from abdominal segments, among them being muscle 33 just internal to muscles 7, 6, 13, and 12. Larval muscle 33 stretches across the other thoracic segments to attach to the mouth parts (Hooper, 1986; Bate, 1993 internal ventral muscles are innervated by branches of segmental nerve b (SNb), including muscle 33 in segment T3 ( Figure 1A) .
At late stage 16learly stage 17, the synaptic arborizations on muscles 7,6,13, and 12 in Al -A7 and on muscle 31 in Al are all easily visualized with MAb lD4 (antifasciclin II) (Figures 3A and 3C) and are accessible to 1 ,l'dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (Dil) backfills in dissected embryos (data not shown). Most of the motoneurons that innervate these muscles can be readily identified in the CNS, penetrated with microelectrodes, and filled with the intracellular dye Lucifer yellow (LY) (Figures 4A and 4B) . In these ways, we can study the innervation of these muscles in wild-type, mutant, and transgenic embryos.
The RP3 growth cone synapses on muscles 7 and 6 in the cleft between these two muscles; RPl and RP4 growth cones synapse on the proximal edge of muscle 13, and (Sink and Whitington, 1991; Van Vactor et al., 1993) . In the present study, we used Dil backfills from the synapse to show that muscle 31 in segment Al is innervated at early stage 17 on its dorsal edge by at least one motoneuron, called DC1 , which has an ipsilateral cell body lateral to the longitudinal connectives (see Figure 1A) . into a synaptic terminal arbor, and on the cleft between muscles 7 and 6 (right arrow in right segment), where in wild type(C) the RP3 growth cone has transformed into a synaptic terminal arbor. Note the absence of the normal terminal arbor on muscle 31 in segment Al and on muscles 7 and 6 in segment A2 in the Toll-semall transgenic embryo (D). Numbers refer to muscle identities. Scale bar, 10 pm.
In contrast with the relative ease of studying the internal ventral muscles in segments Al-A7, the innervation of muscle 33 in segment T3 is very difficult to study because it is innervated on its external face on the opposite side from the surface exposed in dissected embryos. Thus, we do not know the identity of which motoneuron(s) innervates it in wild-type, in mutant, or in transgenic embryos.
During early to mid-stage 16, SNb growth cones make extensive filopodial contact with both their target muscles and adjacent muscles. By late stage 16, these growth cones retract their filopodia on adjacent muscles and form functional synapses on their appropriate target muscles, a process that is complete by early stage 17. Thus, our analysis of growth cone behavior is focused on late stage 1 G/early stage 17 when in wild-type embryos the normal pattern of synaptic innervation is already present.
We first examined embryos homozygous for loss-offunction mutations in the semaphorin II gene, semall (Kolodkin et al., 1993) . Semaphorin II is normally expressed by muscle 33 in segment T3. Using 1 D4 staining, no dramatic loss-of-function phenotype is seen in the pattern of SNb branching around muscle 33 in segment T3 in semall mutant embryos. This observation is reminiscent of previous studies in this same system that showed that the ectopic expression of connectin generates a much stronger and more penetrant phenotype (the gain of function) than does simply removing the protein (the loss of function) (Nose et al., 1994) . With the connectin experiments (Nose et al., 1992 (Nose et al., , 1994 as our paradigm, we next examined the The left focal plane in each pair is on the cleft between muscles 7 and 6, where in wild-type embryos the RP3 growth cone would have transformed into a synaptic terminal arbor. The right focal plane in each pair is external to muscles 7 and 6 and just internal to muscles 14 and 30. This is the region where the FtP3 growth cone is often located in Toll-semell tranegenic embryos at this stage. (A and B) An example of wild-type morphology of the RP3 (A) and RPl (6) Instead of forming a normal synaptic terminal arborization in the cleft between muscles 7 and 6 (C and E), RP3 instead is still a growth cone in the region around muscle 14. See text for further details. Scale bar, 10 pm.
gain-of-function phenotype by ectopically expressing semaphorin II by other ventral muscles whose innervation is well known.
We used P element-mediated transformation to generate ectopic expression of semaphorin II by a different subset of ventral embryonic muscles during motoneuron pathfinding and targeting. We used a heterologous enhancer (from the To// gene) to ectopically express semaphorin II in all segments by some of the ventral muscles that normally do not express it, but that are adjacent to the normally semaphorin II-expressing muscle 33 in segment T3 (see Figures 1C and 28) .
Toll is expressed on a subset of embryonic muscles (Nose et al., 1992) . A 6.5 kb fragment in the 5' flanking region of the Toll gene was previously shown to function as an enhancer element that can drive expression of a lad reporter gene in a subset of muscles (Wharton and Crews, 1993) . At stage 16, /acZ is driven at high levels in muscles 26,14-16,7, and 6 and at lower levels in muscles 30, 17, 13, and some lateral muscles (Nose et al., 1992) ; we also observe /acZ at a high level in muscle 31 in Al and at a lower level in muscle 33 in T3.
This 6.5 kb fragment of the Toll gene was previously used to ectopically express connectin (Nose et al., 1994) and here it was used ectopically to express semaphorin II by these ventral muscles (see Figures 1C and 28) . The construct contains the 6.5 kb Toll enhancer, the hsp70 promoter, a semall cDNA with the entire open reading frame, and the SV40 polyadenylation site, all inserted into Toll-semall transformant lines were isolated, three of which are analyzed here (Table 1) .
As expected, semall mRNA is ectopically expressed by the normally Toll-positive ventral muscle fibers in Tollsemall embryos (see Figure 28 ). The ectopic muscle expression is first detected at stages 1 l-l 2, peaks at stages 14-15, and declines during stage 16. It is strongest in muscles 26, 14-16, 7, and 6. By late stage 16, ectopic semall mRNA expression can no longer be detected. The 6.5 kb Toll enhancer drives expression of a reporter IacZ gene in some other tissues known to express Toll, including the dorsal vessel (Wharton and Crews, 1993) . Ectopic semall mRNA expression persists into stage 17 in the dorsal vessel, thus allowing for the unambiguous identification of embryos carrying the transgene at this stage.
No gross defects are seen in the CNS or in the periphery in the Toll-semall embryos. The development of the muscles that ectopically express semaphorin II appears normal in Toll-semall embryos, as indicated both by their morphology (as visualized with Nomarski optics) and their expression of various other surface markers (fasciclin Ill and fasciclin II) during stages 15-l 7. The timing and morphology of the differentiation of the muscle pioneers, muscle insertions, and myoblast fusions to the pioneers are normal in the semaphorin h-expressing muscles in these embryos. These observations suggest that the ectopic expression of semaphorin II does not alter the differentiation of ventral muscles per se.
The innervation of muscles 7 and 6 by the RP3 motoneuron is dramatically altered in Toll-semall embryos (see Figure3B; Table 1 ); innervation is used here as an anatomical description of the normal terminal synaptic arborization in the cleft between muscles 7 and 6. In Toll-semall embryos, muscles 7 and 6 appear uninnervated in 53%-66% of segments at late stage 16 (depending upon which line is examined; see Table 1 ). A prominent feature of the abnormal SNb projection at this stage is the large growth cone processes emanating from the SNb axons just beyond muscle 14 and near to or in contact with muscle 30. During mid-stage 17, several hours after ectopic semaphorin II expression has disappeared, muscles 7 and 6 remain uninnervated in 270/o-29% of segments. In contrast, in wild-type embryos of the same genetic background but lacking the Toll-semall transgene, muscles 7 and 6 are innervated in >97% of segments at late stage 16 and 100% of segments at mid-stage 17.
Intracellular dye fills of the RP3 motoneuron (Sink and Whitington, 1991) in Toll-semall embryos (line 6651665) at late stage lG/early stage 17 confirm this result: 11 of 16 RP3 axons (69%) were abnormal. Instead of forming the normal synaptic terminal arborization in the cleft between muscles 7 and 6 ( Figures 4C and 4E ), these RP3 growth cones are instead just external to muscles 7 and 6, near muscle 14 and often near muscle 30 as well (Figures 4A and 4B, Figures 4C and 4D, and Figures 4E and 4F show different focal planes of the same preparations). These results are summarized in Figure 58 . Although the muscles appear normal in Toll-semall emAs a control, the innervation of muscle 13 by both RPl bryos, we observe abnormalities in the development of and RP4 appears unperturbed in 100% of segments in certain branches of the SNb motor nerve that normally Toll-semall embryos (Table 1 ). Muscle 13 is likely to exinnervate muscles 7 and 6 in all abdominal segments and press low levels of semaphorin II in Toll-semall embryos. muscle 31 in Al. We observe the same phenotypes in all
In addition, to reach muscle 13, the motoneurons that inthree Toll-semall lines examined (Table 1 ). The effects of nervate it (RPl and RP4) normally extend between musectopic semaphorin II expression are specific to SNb and cles that express very high levels of semaphorin II in TollSNd motoneurons. The other three motor nerves (the intersemall embryos (e.g., in the region between muscles 15, segmental nerve, SNa, and SNc) retain their normal mor-26,14,7, and 6) (see Figures 1 and 5 ). This axon trajectory phology and branching in Toll-semall embryos. The SNd appears normal in Toll-semall embryos. Moreover, intramotoneurons, which normally innervate muscles 15-l 7 cellular dye fills of RPl in Toll-semallembryos at late stage (which ectopically express semaphorin II in Toll-semall 1 G/early stage 17 reveal that 7 of 7 RPl axons follow their embryos), display less severe abnormalities at similar frenormal trajectory to innervate the inner surface of muscle quencies to the SNb in these embryos.
13 (Figure 58 15, 16, 28, 14, 7 , and 6 and at much lower levels by muscles 17 and 13. The RP3 motoneuron shows dramatic abnormalities, typically entering the ventral muscle field at the normal location and extending to the region near muscle 14, but (so long as semaphorin II is expressed) failing to innervate muscles 7 and 6. RPI appears wild type in these embryos.
We also examined the innervation of muscle 31 in segment Al in Toll-semall embryos. Muscle 31 expresses high levels of semaphorin II in these embryos. The DC1 motoneuron, which innervates muscle 31, normally follows the same trajectory as the RPI motoneuron innervating muscle 13 (see Figure 1A) . Instead of innervating the inner surface of muscle 13, DC1 extends inward to innervate the dorsal surface of muscle 31 (see Figures 1 and  3C ). In Toll-semallembryos, DC1 is abnormal. In wild-type embryos, muscle 31 is innervated in 100% of Al segments at late stage 16 (Table 1) . However, in Toll-semall embryos, DC1 does not innervate muscle 31 in 60%-60% of segments at mid-stage 17 (see Figure 3D) , depending upon the line examined (Table 1 ; because there is only one Al segment per embryo, the total number of Al segments examined is much lower than A2-A7, and thus the differences between different lines and stages are not significant).
The phenotypes observed with MAb 1 D4 staining (see Figure 3 ) do not qualitatively change in embryos from three different transgenic lines carrying independent insertions that drive different levels of expression and, as a result, different levels of phenotypic penetrance (Table 1 ). The phenotypes also do not qualitatively change in embryos carrying four copies of the transgene as compared with two copies (Table 1 ). The penetrance of the muscle 6/7 phenotype increases slightly (from 53%-68% in the two parental two-copy lines to 74% in the combined four-copy line), but no new phenotypes are observed in embryos carrying an increased copy number. Most important, in all lines and all dosages, the RP3 growth cone enters the ventral muscle region but stalls near muscle 14 and fails to form its synaptic terminal arborization on its normal target muscles 7 and 6. All that changes is the penetrance of this phenotype.
Discussion
The present study shows that semaphorin II in Drosophila can function in vivo as a target-derived signal that inhibits the formation of synaptic terminal arbors. In contrast with connectin (Nose et al., 1994) netrin-1 (Colamarino and Tessier-Lavigne, 1995 [this issue of Ce//)), and semaphorin Ill (Messersmith et al., 1995) which can function as repellents for growth cone pathfinding, semaphorin II appears to be able to function in vivo in a qualitatively different fashion as an inhibitor of synapse formation during target recognition.
Semaphorin II is transiently expressed by a single large ventral muscle in segment T3 during motoneuron outgrowth. We tested the in vivo function of semaphorin II by creating transgenic Drosophila that generate ectopic semaphorin II expression by other ventral muscles in thoracic and abdominal segments that normally do not express it. The results lead to three major conclusions.
First, when semaphorin II is ectopically expressed by many ventral muscles along the SNb pathway, the RPl and RP4 growth conesare unperturbed in their pathfinding toward their target, muscle 13 (which does express semaphorin II, but at considerably lower levels than by the targets of RP3, muscles 7 and 6). These growth cones pathfind right between muscles 15, 28, 14, 7, and 6, which express high levelsof semaphorin II. Thus, the pathfinding of these growth cones (and perhaps their targeting as well) appears unresponsive to semaphorin II. Moreover, there is nothing intrinsically nonpermissive about the SNb pathway in the Toll-semall embryos.
Second, when semaphorin II is ectopically expressed at high levels by muscles 7 and 6 (the normal targets for RP3), the RP3 growth cone is inhibited from forming a normal synaptic terminal arborization with its two target muscles. Similarly, when semaphorin II is ectopically expressed by muscle 31 in segment Al, DC1 is also inhibited from forming its normal synaptic arborization. These results indicate that semaphorin II can function as a targetderived inhibitor.
Third, the RP3 growth cone, while inhibited from forming its synaptic arborization, is not prevented from extending into the region of muscles expressing high levels of semaphorin II. It extends within several microns of muscles 15, 28, 14, 7, and 6 and is often located in close proximity to muscle 14. All of these muscle8 express high levels of semaphorin II. This result indicates that for certain neurons, semaphorin II can inhibit the growth cone from form-ing a synaptic arborization, without repelling growth into the region where the protein is expressed.
Taken together, these results suggest that the RP3 and DC1 growth cones express a semaphorin II receptor on their surface that confers an inhibitory response to this signal. The RPl and RP4 growth cones either do not express this receptor or, alternatively, express the receptor but are nevertheless unresponsive to semaphorin II. As discussed below, this putative semaphorin II receptor on the RP3 and DC1 growth cones can prevent growth cone branching and exploration and inhibit them from forming synaptic arborizations, but it does not appear to deter growth cone pathfinding.
The Guidance Functions of Semaphorin II versus Connectin Insight thus far into how semaphorin II and connection function during pathfinding and targeting has come largely from gain-of-function experiments using ectopic expression. The RPl growth cone clearly behaves quite differently when the two guidance signals are ectopically expressed by the same muscles. In the semaphorin II experiments, FiPl appears unresponsive, extending along its normal trajectory and innervating muscle 13 in a normal fashion. In contrast, in the connectin experiments (Nose et al., 1994) , RPl changes its trajectory and takes a detour to reach muscle 13, thus avoiding the ectopic connectinexpressing muscles. These results suggest that the RPl growth cone expresses a functional receptor for connectin that confers a repulsive role during pathfinding, but not for semaphorin II.
In one respect, the RP3growth cone behaves similarly in both experiments, being inhibited from forming a synaptic arborization on its normal targets (muscles 7 and 6) when they ectopically express either molecule. These results indicate that RP3 expresses receptors for both signals. However, there is also one interesting difference in the RP3 growth cone behavior in the two experiments. When connectin is ectopically expressed, RP3 does not enter the ventral muscle field in the normal location, but rather either stalls at this location or detours around the connectin-expressing muscles. Thus, connectin appears to repel RP3 pathfinding. In contrast, when semaphorin II is ectopically expressed at the same time by the same muscles, RP3 behaves quite differently. RP3 enters the ventral muscle field in the normal location. RP3 only stalls when it nears its semaphorin h-expressing target muscles.
It is possible that the qualitative differences in RP3 behavior simply reflects quantitative differences in the levels of expression of the two guidance signals. Arguing in favor of real qualitative differences in responsiveness, however, are the observations on penetrance and dosage. In each experiment, RP3 was examined in multiple independent transgenic lines with independent insertions and with different copy number of insertions (e.g., homozygous versus heterozygous) driving different levels of expression. Nevertheless, the only differences observed were in the penetrance of the RP3 phenotype, not in the quality of the phenotype. Moreover, these different lines drive expression of both connectin protein and semall RNA that appears to be within the normal range of biological expression, suggesting that these qualitative differences are biologically significant. These results suggest that connectin functions as a repellent for RP3 pathfinding and targeting, while semaphorin II functions in a qualitatively different fashion to inhibit the formation of RP3 synaptic arborizations on muscles 7 and 6. This qualitative difference in RP3 behavior when exposed to connectin versus semaphorin II could be explained by differences in either the timing or the quality of receptor-mediated response. In the first model, RP3 is equally inhibited by both semaphorin II and connectin, but simply expresses functional semaphorin II-repulsive receptors at a later time during its journey toward its target muscles. In the second model, the quality of the response to the two signals is different, connectin equally repelling the RP3 growth cone during both pathfinding and targeting, with semaphorin II inhibiting RP3 during targeting while not repelling its axon growth.
These results suggest that neuromuscular specificity is controlled by a combination of attraction versus inhibition, repulsion, or both, that these signals can either be secreted or cell surface, that different motoneuron growth cones express different combinations of receptors, and that these receptor systems can function in either pathfinding or targeting or in both events. In such a model, different types of inhibitory and repulsive molecules play different roles in establishing the final pattern of axon projections and synaptic connections. In this way, each motoneuron has its own particular response profile in terms of both its pathfinding and targeting preferences.
Inhibitory and Repulsive Functions of Semaphorins
These observations on semaphorin II function in the Drosophila embryo are similar in certain respects to previous results on semaphorin I function in the grasshopper limb bud (Kolodkin et al., 1992) . Semaphorin I functions tostall and then steer the pair of Ti 1 growth cones as they encounter a stripe of epithelial cells expressing it. The expression of semaphorin I on epithelial cells prevents the Til axons that encounter it from defasciculating and inhibits branching. However, although having a potent affect on their steering, fasciculation, and branching, the Til growth cones are still able to grow on the semaphorin I-expressing cells (see discussion in Kolodkin et al., 1993) . Similarly, as shown here in Drosophila, RP3 enters into the region of muscles expressing semaphorin II, but it fails to form synaptic arborizations on its targets.
An interesting comparison can also be made between the in vivo results reported here and previously (Kolodkin et al., 1992) for semaphorin I and semaphorin II function in insects and the in vitro results reported previously for retinal ganglion growth cones in the rat (Roskies and O'Leary, 1994) . In an in vitro stripe assay, temporal retinal axons can extend across alternating membranes from the topographically correct rostra1 superior colliculus and the incorrect caudal superior colliculus of embryonic rats. They are not repelled by the incorrect membranes, but rather preferentially branch on the correct membranes and do not branch on the wrong ones. This branching prefer-ence is due to a molecule in the caudal superior colliculus that inhibits branching of temporal retinal axons. These results lead to the suggestion that in certain contexts, some guidance molecules may inhibit axon branching without repelling axon growth (Roskies and O'Leary, 1994) .
For the Drosophila RP3growth cone in vivo, semaphorin II does not appear to repel axon growth, but rather does behave as a potent inhibitor of synapse formation. For mammalian sensory axons in vitro, semaphorin Ill can function as a selective chemorepellent (Messersmith et al., 1995) . Whether these differences in inhibition versus repulsion are biologically significant or simply reflect the different types of in vivo and in vitro assays used remains to be determined. In the developing organism, semaphorins appear capable of inhibiting branching (semaphorin I in grasshopper), influencing steering decisions (semaphorin I in grasshopper and semaphorin Ill in mammals), preventing axons from entering certain target regions (semaphorin II in Drosophilaand perhapssemaphorin Ill in mammals), or inhibiting the formation of synaptic terminal arborizations (semaphorin II in Drosophila). It is possible that the same molecule may play different roles in different contexts within the same developing organism. In this regard, it will be important in the future to identify the receptor(s) for semaphorins and begin to elucidate their signal transduction mechanisms in these different contexts.
The Loss of Function versus the Gain of Function One finding in the present study is that the ectopic expression of semaphorin II generates a much stronger and more penetrant phenotype (the gain of function) than does simply removing the protein (the loss of function). A similar conclusion was reached in the previous analysis of connectin function (Nose et al., 1994) and in a recent analysis of fasciclin Ill function in this same system (Chiba et al., 1995) . This striking trend, in which the ectopic expression of three different targeting molecules yields stronger phenotypes than the loss of function, must reflect some inherent property in the way targeting systems are built. For example, the identity of a target may be specified not by a single molecule, but rather by a combination of different molecules, each of which is interpreted as either attractive or repulsive by particular growth cones depending upon the combination of receptors they express. If this is correct, then the introduction of one of these components in a novel location might have a more disruptive effect on the final outcome than would removal of any one component.
Based on our analysis of connectin function (Nose et al., 1994) , we previously suggested that some guidance molecules may be in part refractory to loss-of-function genetic analysis in which gene functions are removed one at a time. Rather, molecular genetic methods that rely on the ectopic expression of these molecules may be required to reveal their function more clearly. Previous systematic genetic screens for mutations with highly penetrant phenotypes that perturb specific aspectsof neuromuscular specificity in the Drosophila embryo did not recover mutations in either the semall, connectin, or faslll genes (Van Vactor et al., 1993; Sink and Goodman, 1994, Sot. Neurosci., abstract) . And yet all three of these genes appear to encode important targeting signals in this system (Nose et al., 1994; Chiba et al., 1995; this paper (Wharton and Crews, 1993) was then inserted 5' to the hsp70 promoter in the pCaSpeR-semall construct to form the expression constructpCaSpeR-Toll-semall.
Each newly formed junction was sequenced with pCa.SpeR-specific primers.
The pCaSpeR-Toll-semall construct was introduced into w"'~ embryos by P element-mediated transformation (Spradling and Rubin, 1982) with the helper plasmid pUChspAP-3.
We established 13 independent transformants lines, including 457, 483, and 685, each with an insert on chromosome 2, and 78 and 687, each with an insert on chromosome 3. Most have near wild-type levels of semall mRNA expression in the To// muscle pattern (highest in muscles 14-16; less in 17, 7, and 6; and lower still in 5, 22-24, and 31) as compared with the normal expression in muscle 33 in segment T3.
Genetics
Loss-of-function analysis was done using homozygous line 3021 reel 4, a recombined derivative of PI .O (Kolodkin et al., 1993 ) that has a rosy P element inserted in codon 33 of the semall open reading frame.
This recombinant line is homozygously semiviable and fertile (M. Winberg and A. L. K., unpublished data), although the adults behave abnormally in visual orientation tests and hold their wings in an abnormal posture (Kolodkin et al., 1993 fixed, and devitellinized as described in Pate1 et al. (1987) . Embryos were stained with the following antibodies using standard protocols: MAd lD4 (anti-fasciclin II; G. l-felt and C. S. G., unpublished data; see Van Vactor et al., 1993) , MAb 22ClO (Fujita et al., 1982) , and anti-p-galactosidase (gift from Ft. Holmgren). Embryos were dissected as described elsewhere (Van Vactor et al., 1993; Kolodkin et al., 1993) .
Staging of embryos was according to Campos-Drtega and Hartenstein (1985) and Van Vactor et al. (1993) , with particular attention to head involution, CNS condensation, gut morphology, and appearance of MAb 1 D4 staining of the lateral longitudinal axon tracts. Muscle identity and nomenclature are from Crossley (1978) , Hooper (1988), and Bate (1993) . In situ hybridization was performed as described by Kolodkin et al. (1993) .
Intracellular
Dye Fills Individual RP motoneurons (RPl and RP3) were visualized with Nomarski optics in unfixed, dissected late stage 18 embryos, identified according to their cell body positions between the axon commissures, penetrated with microelectrodes, iontophoretically injected with LY as described previously (Sink and Whitington, 1991) , and processed using anti-LY antibody (Molecular Probes) (Taghert et al., 1982) . Motoneuron DC1 was identified by iontophoretic application of Dil (0.4% in ethanol) to the axon of the lateral surface of muscle 31 in segment Al. After 15 min, the embryo was fixed for 15 min in 4% formalin-citrate phosphate buffer, rinsed extensively with PBS for 30 min, and then photo-oxidized with DAB (1 mglml) under a rhodamine filter set until brown reaction product wasseen in the backfilled neuron.
